Congress

Coste-efectividad de ipilimumab en el tratamiento de primera línea de pacientes con melanoma avanzado en España

Authors: Aceituno S, Canal C, Paz S, González P, Márquez-Rodas I

Year: 2014

Congress: XI Reunión Científica de la Asociación Española de Evaluación de Tecnologías (AEET)


Subscribe to Outcomes´10
Todos los campos marcados con un * son obligatorios
Responsible for the data: Outcomes'10, s.l.u., Purpose: Sending commercial communications. Legitimation: Art. 6.1 Consent of the interested party. Recipient: No data is transferred unless expressly authorised. You may exercise your rights on data protection (access, rectification, opposition, deletion, automated decisions, limitation of treatment, portability) by email at dpo@outcomes10.com. In any case, you can request the protection of the Spanish Data Protection Agency through its website www.aepd.es/. In addition, you can consult more information on the privacy policy
Logo
Aenor gestión de calidad
Aenor seguridad e información
Logotipo
Skip to content